Cma. Nieuwenhuys et al., HYPOCOAGULANT AND LIPID-LOWERING EFFECTS OF DIETARY N-3 POLYUNSATURATED FATTY-ACIDS WITH UNCHANGED PLATELET ACTIVATION IN RATS, Arteriosclerosis, thrombosis, and vascular biology, 18(9), 1998, pp. 1480-1489
We investigated the effects of dietary polyunsaturated fatty acids (PU
FAs) on blood lipids and processes that determine hemostatic potential
: platelet activation, coagulation, and fibrinolysis. For 8 to 10 week
s, Wistar rats were fed a high-fat diet containing various amounts (2%
to 16%) of n-3 PUFAs derived from fish oil (FO) or a diet enriched in
n-6 PUFAs from sunflower seed oil (SO). Only the FO diets caused a re
duction in mean platelet volume, platelet arachidonate level, and form
ation of thromboxane B-2 by activated platelets, but neither of the di
ets had a measurable effect on platelet activation. The FO-rich diets
decreased the plasma concentrations of triglycerides and cholesterol,
whereas the SO diet reduced triglycerides only. Parameters of fibrinol
ysis and standard coagulation times, ie, activated partial thromboplas
tin time and prothrombin time, were only marginally influenced by thes
e diets. In contrast, dietary FO, but not SO, led to decreased levels
of the vitamin K-dependent coagulation factors prothrombin and factor
VII, while the level of antithrombin III was unchanged. The endogenous
thrombin potential (ETP) was measured with an assay developed to dete
ct the hypocoagulable state of plasma. After activation with tissue fa
ctor and phospholipids, the ETP was reduced by 23% or more in plasma f
rom animals fed a diet with >4% FO. No significant effect of the SO di
et on ETP was observed. Control experiments with plasma from warfarin-
treated rats indicated that the ETP was more sensitive to changes in p
rothrombin concentration than in factor VII concentration. Taken toget
her, these results indicate that in rats, prolonged administration of
n-3 but not n-6 PUFAs can lead to a hypocoagulable state of plasma thr
ough a reduced capacity of vitamin K-dependent thrombin generation, wi
th unchanged thrombin inactivation by antithrombin III.